Psilocybin mushrooms illustration

Optimi Health to enter Asia with psilocybin research collaboration

Optimi Health (CSE:OPTI) announces a supply partnership with PsiloThai, a Thailand-based patient advocacy group.
Image description: an AI generated photo with a stethoscope

WELL Health receives C$15.3 million in funding for AI healthtech

WELL Health Technologies (TSX:WELL) locks in C$15.3 million in funding for a project to develop artificial intelligence health technology.
Theratechnologies image of a lab technician handling samples

Theratechnologies stock jumps on positive income report

Theratechnologies stock (TSX:TH) opens nearly 4 per cent higher on Wednesday on the release of its latest financial results.
People negotiating in a meeting room

ME Therapeutics to collaborate with NanoVation Therapeutics

ME Therapeutics (CSE:METX) reveals it has entered into a collaboration with NanoVation Therapeutics on myeloid cancer treatments.
A man looking at different kinds of financial charts

DRI Healthcare stock drops 28% after executive changes

DRI Healthcare Trust (TSX:DHT.UN) stock drops after making executive changes from an ongoing investigation of former CEO Behzad Khosrowshahi.
Defence Therapeutics image of immune system cells

Defence Therapeutics touts anticancer treatment and immune booster

Defence Therapeutics (CSE:DTC) states that its anticancer treatment, AccuTOX is working as a tumor-killing molecule and as an immune booster.
Sunflowers in the sun

Buzz on the Bullboards: Whose stocks sizzle during summer holidays?

The calmer market environment of summer holidays is a prime opportunity for investors to evaluate portfolios and consider new investments.
UniDoc Health's AI-powered H3 Health Cube

UniDoc brings AI-powered H3 Health Cube to Italy

UniDoc (CSE:UDOC) is working with the Municipality of Aliano in Italy to install an H3 Health Cube at the Territorial Health Centre.
Technician holding blood tube test in a research laboratory

Quest Diagnostics to acquire LifeLabs from OMERS for C$1.35 billion

Quest Diagnostics (NYSE:DGX) signs an agreement to acquire LifeLabs from OMERS in a C$1.35 billion deal, including net debt.
From left, Dr. Lior Shaltiel, Professor Michael Belkin, Professor Ygal Rotenstreich and Dr. Ifat Sher

New treatment studied in $3.4 billion glaucoma market

A pre-clinical study launches to explore the potential of NurExone’s (TSXV:NRX) exosome-based therapies in regenerating damaged optic nerves.
Screenshot of Dr. Monica Perez being interviewed by NBC5 Chicago

NervGen: Are amazing human trial results leaking out?

NervGen Pharma Corp. (TSXV:NGEN) hopes to commercialize the world’s first ever FDA-approved drug to treat spinal cord injuries.

Optimi Health makes commercial entry into Australia

Optimi Health (CSE:OPTI) receives three export permits from Health Canada to supply GMP MDMA and psilocybin to Australia.
Image description: an AI generated photo with a stethoscope

Healwell AI reduces radiation burden for cancer patients

Pentavere, a subsidiary of Healwell AI (TSX:AIDX), announces new research accepted at two medical conferences.
clinical trial

Sona Nanotech’s therapy shines in cancer trials

Sona Nanotech (CSE:SONA) revels that its targeted hyperthermia therapy has shown positive results in a second preclinical cancer model.

MediPharm bolsters revenue with new medical cannabis products

MediPharm Labs (TSX:LABS), a cannabis pharmaceutical stock, increases revenue through a new licensing agreement with Remidose Aerosols.

Sparta and Parametric join forces to advance autonomous medicine project

Sparta Group (TSX.V:SAY) signed a strategic partnership with Parametric Design Canada Inc., a leader in augmented reality (AR) technologies.

MindBio’s microdosed LSD reduces depression post treatment

MindBio (CSE:MBIO), a psychedelic healthcare stock, reports a sustained 65% reduction in depressive symptoms in its phase 2A clinical trial.